126 related articles for article (PubMed ID: 19298528)
1. A common hereditary single-nucleotide polymorphism in the gene of FAS and colorectal cancer survival.
Hofmann G; Langsenlehner U; Langsenlehner T; Yazdani-Biuki B; Clar H; Gerger A; Fuerst F; Samonigg H; Krippl P; Renner W
J Cell Mol Med; 2009 Sep; 13(9B):3699-702. PubMed ID: 19298528
[TBL] [Abstract][Full Text] [Related]
2. The FAS -670A>G polymorphism influences susceptibility to systemic sclerosis phenotypes.
Broen J; Gourh P; Rueda B; Coenen M; Mayes M; Martin J; Arnett FC; Radstake TR;
Arthritis Rheum; 2009 Dec; 60(12):3815-20. PubMed ID: 19950259
[TBL] [Abstract][Full Text] [Related]
3. The role of FAS gene variants in inflammatory bowel disease.
Demir A; Kahraman R; Candan G; Ergen A
Turk J Gastroenterol; 2020 May; 31(5):356-361. PubMed ID: 32519954
[TBL] [Abstract][Full Text] [Related]
4. IL6 and FAS/FASL gene polymorphisms may be associated with disease progression in HIV-1-positive ethnically mixed patients.
Loureiro Dos Reis MM; Queiroz MAF; da Silva BCM; da Silva Duarte AJ; Casseb J; Arganaraz GA; Vallinoto ACR; Argañaraz ER
J Med Virol; 2020 Aug; 92(8):1148-1157. PubMed ID: 31825106
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
[TBL] [Abstract][Full Text] [Related]
6. FAS-670A/G polymorphism: A biomarker for the metastasis of nasopharyngeal carcinoma in a Chinese population.
Zhu Q; Wang T; Ren J; Hu K; Liu W; Wu G
Clin Chim Acta; 2010 Feb; 411(3-4):179-83. PubMed ID: 19895798
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
[TBL] [Abstract][Full Text] [Related]
8. FAS -670A>G promoter polymorphism is associated with soluble Fas levels in primary Sjögren's syndrome.
Treviño-Talavera BA; Palafox-Sánchez CA; Muñoz-Valle JF; Orozco-Barocio G; Navarro-Hernández RE; Vázquez-Del Mercado M; García de la Torre I; Oregon-Romero E
Genet Mol Res; 2014 Jul; 13(3):4831-8. PubMed ID: 25062418
[TBL] [Abstract][Full Text] [Related]
9. Association of FAS-670A/G and FASL-844C/T polymorphisms with idiopathic azoospermia in Western Iran.
Asgari R; Mansouri K; Bakhtiari M; Bidmeshkipour A; Yari K; Shaveisi-Zadeh F; Vaisi-Raygani A
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():55-59. PubMed ID: 28942044
[TBL] [Abstract][Full Text] [Related]
10. Significant association among the Fas -670 A/G (rs1800682) polymorphism and esophageal cancer, hepatocellular carcinoma, and prostate cancer susceptibility: a meta-analysis.
Liu T; Zuo L; Li L; Yin L; Liang K; Yu H; Ren H; Zhou W; Jing H; Liu Y; Kong C
Tumour Biol; 2014 Nov; 35(11):10911-8. PubMed ID: 25085585
[TBL] [Abstract][Full Text] [Related]
11. Correlation between FAS single nucleotide polymorphisms and breast carcinoma susceptibility in Asia.
Chen Y; Wang H; Yan Y; Ren M; Yan C; Wang B
Medicine (Baltimore); 2019 Dec; 98(49):e18240. PubMed ID: 31804351
[TBL] [Abstract][Full Text] [Related]
12. FAS -670A>G genetic polymorphism Is associated with Treatment Resistant Depression.
Santos M; Carvalho S; Lima L; Mota-Pereira J; Pimentel P; Maia D; Correia D; Gomes S; Cruz A; Medeiros R
J Affect Disord; 2015 Oct; 185():164-9. PubMed ID: 26186532
[TBL] [Abstract][Full Text] [Related]
13. Association between the FAS rs2234767G/A polymorphism and cancer risk: a systematic review and meta-analysis.
Wang X; Xing GH; Fan CC
DNA Cell Biol; 2014 May; 33(5):320-7. PubMed ID: 24568648
[TBL] [Abstract][Full Text] [Related]
14. Single-Nucleotide Polymorphisms of FAS and FASL Genes and Risk of Idiopathic Aplastic Anemia.
Rehman S; Saba N; Naz M; Ahmed P; Munir S; Sajjad S; Tabassum S; Naseem L
Immunol Invest; 2018 Jul; 47(5):484-491. PubMed ID: 29611722
[TBL] [Abstract][Full Text] [Related]
15. Single nucleotide polymorphisms of genes for EGF, TGF-β and TNF-α in patients with pancreatic carcinoma.
Zhang L; Wu G; Herrle F; Niedergethmann M; Keese M
Cancer Genomics Proteomics; 2012; 9(5):287-95. PubMed ID: 22990108
[TBL] [Abstract][Full Text] [Related]
16. Association of Fas-670 gene polymorphism with risk of cervical cancer in North Indian population.
Kordi Tamandani DM; Sobti RC; Shekari M
Clin Exp Obstet Gynecol; 2008; 35(3):183-6. PubMed ID: 18754288
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of TP53 and FAS promoter modulate the progression of coronary artery disease after coronary artery bypass grafting: a gender-specific view.
Beiras-Fernandez A; Angele MK; Koutang C; Lohse P; Reichart B; Lohse P; Eifert S
Inflamm Res; 2011 May; 60(5):439-45. PubMed ID: 21286777
[TBL] [Abstract][Full Text] [Related]
18. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
[TBL] [Abstract][Full Text] [Related]
19. The FAS-670 AA genotype is associated with high proviral load in peruvian HAM/TSP patients.
Rosado J; Morales S; López G; Clark D; Verdonck K; Gotuzzo E; Van Camp G; Talledo M
J Med Virol; 2017 Apr; 89(4):726-731. PubMed ID: 27603042
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.
Sun T; Miao X; Zhang X; Tan W; Xiong P; Lin D
J Natl Cancer Inst; 2004 Jul; 96(13):1030-6. PubMed ID: 15240787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
